糖尿病性视网膜病变个性化视网膜光凝术的有效性分析(1)
DOI：10.16658/j.cnki.1672-4062.2019.22.010
[摘要] 目的 评析糖尿病性视网膜病变个性化视网膜光凝术的有效性，为后续的临床应用奠定理论基础。 方法 选取该院2018年2—12月收治的30例糖尿病性视网膜病变患者，37只眼进行个性化视网膜光凝术治疗，观察治疗有效性，对视力的影响及患者满意度等。结果 针对不同程度患者的治疗效果分析，NPDR患者治愈有效率为84.62%，PDR患者为81.82%。两组治愈率均在80.00%以上。NPDR患者有7.69%发生视力降低，PDR为9.09%，总的视力下降比例为8.11%。NPDR患者出现1例视网膜出血，占比为3.85%;PDR患者发生1例视网膜出血，占比为9.09%;总的不良反应发生率为5.41%。 结论 个性化视网膜光凝术根据不同患病程度进行针对性调整，治疗有效率较高且不良反应发生率较低，可以在实践中大范围推广使用。
[关键词] 糖尿病性;视网膜病变;个性化视网膜光凝术;有效性
[中图分类号] R779.6 [文献标识码] A [文章编号] 1672-4062(2019)11(b)-0010-02
Analysis of the Effectiveness of Personalized Retinal Photocoagulation for Diabetic Retinopathy
XU Ke-feng， YIN Jun-tao
Department of Ophthalmology， Xishan People's Hospital， Wuxi， Jiangsu Province， 214105 China
[Abstract] Objective To evaluate the effectiveness of personalized retinal photocoagulation for diabetic retinopathy and lay a theoretical foundation for subsequent clinical application. Methods Thirty patients with diabetic retinopathy admitted to the hospital from February to December 2018 were enrolled in this study. 37 eyes underwent personalized retinal photocoagulation to observe the effectiveness of treatment， visual acuity and patient satisfaction. Results According to the analysis of the therapeutic effects of patients with different degrees of disease， the effective rate of NPDR patients was 84.62%， and that of PDR patients was 81.82%. The cure rate of both groups was above 80.00%. In NPDR patients， 7.69% had decreased vision， PDR was 9.09%， and the total visual acuity decreased by 8.11%. 1 patient with NPDR had retinal hemorrhage， accounting for 3.85%; 1 patient with PDR had retinal hemorrhage， accounting for 9.09%; the overall adverse reaction rate was 5.41%. Conclusion Personalized retinal photocoagulation is adjusted according to different degrees of disease. The treatment is effective and the incidence of adverse reactions is low. It can be widely used in practice.
[Key words] Diabetic; Retinopathy; Personalized retinal photocoagulation; Effectiveness
隨着生活环境及方式的改变，糖尿病的发病率日益增高，尤其是中老年群体易高发。糖尿病性视网膜病变是糖尿病的主要并发症之一，据报道其发生率达到45%左右[1]。视网膜病变可分为非增生性糖尿病视网膜病变(NPDR)和增生性糖尿病视网膜病变 (PDR)。目前主要的治疗方法为药物预防及激光治疗[2]。该文以2018年2—12月收治的30例患者为对象，详细分析了个性化视网膜光凝术的治疗有效性，报道如下。
1 资料与方法
1.1 一般资料
选取该院收治的30例糖尿病性视网膜病变患者，37只眼，其中男性19例23眼，女性11例14眼，年龄53～74岁，平均年龄(64.09±3.22)岁;体重45～75 kg，平均体重(57.09±5.33)kg;视力范围 0.06～0.9，平均视力(0.57±0.07);糖尿病病程 3 ～15 年，平均病程(9.76±1.57)年;其中非增生性糖尿病视网膜病变(NPDR)21例26眼，增生性糖尿病视网膜病变 (PDR)9例11眼。, 百拇医药(许科锋，殷俊涛)
[摘要] 目的 评析糖尿病性视网膜病变个性化视网膜光凝术的有效性，为后续的临床应用奠定理论基础。 方法 选取该院2018年2—12月收治的30例糖尿病性视网膜病变患者，37只眼进行个性化视网膜光凝术治疗，观察治疗有效性，对视力的影响及患者满意度等。结果 针对不同程度患者的治疗效果分析，NPDR患者治愈有效率为84.62%，PDR患者为81.82%。两组治愈率均在80.00%以上。NPDR患者有7.69%发生视力降低，PDR为9.09%，总的视力下降比例为8.11%。NPDR患者出现1例视网膜出血，占比为3.85%;PDR患者发生1例视网膜出血，占比为9.09%;总的不良反应发生率为5.41%。 结论 个性化视网膜光凝术根据不同患病程度进行针对性调整，治疗有效率较高且不良反应发生率较低，可以在实践中大范围推广使用。
[关键词] 糖尿病性;视网膜病变;个性化视网膜光凝术;有效性
[中图分类号] R779.6 [文献标识码] A [文章编号] 1672-4062(2019)11(b)-0010-02
Analysis of the Effectiveness of Personalized Retinal Photocoagulation for Diabetic Retinopathy
XU Ke-feng， YIN Jun-tao
Department of Ophthalmology， Xishan People's Hospital， Wuxi， Jiangsu Province， 214105 China
[Abstract] Objective To evaluate the effectiveness of personalized retinal photocoagulation for diabetic retinopathy and lay a theoretical foundation for subsequent clinical application. Methods Thirty patients with diabetic retinopathy admitted to the hospital from February to December 2018 were enrolled in this study. 37 eyes underwent personalized retinal photocoagulation to observe the effectiveness of treatment， visual acuity and patient satisfaction. Results According to the analysis of the therapeutic effects of patients with different degrees of disease， the effective rate of NPDR patients was 84.62%， and that of PDR patients was 81.82%. The cure rate of both groups was above 80.00%. In NPDR patients， 7.69% had decreased vision， PDR was 9.09%， and the total visual acuity decreased by 8.11%. 1 patient with NPDR had retinal hemorrhage， accounting for 3.85%; 1 patient with PDR had retinal hemorrhage， accounting for 9.09%; the overall adverse reaction rate was 5.41%. Conclusion Personalized retinal photocoagulation is adjusted according to different degrees of disease. The treatment is effective and the incidence of adverse reactions is low. It can be widely used in practice.
[Key words] Diabetic; Retinopathy; Personalized retinal photocoagulation; Effectiveness
隨着生活环境及方式的改变，糖尿病的发病率日益增高，尤其是中老年群体易高发。糖尿病性视网膜病变是糖尿病的主要并发症之一，据报道其发生率达到45%左右[1]。视网膜病变可分为非增生性糖尿病视网膜病变(NPDR)和增生性糖尿病视网膜病变 (PDR)。目前主要的治疗方法为药物预防及激光治疗[2]。该文以2018年2—12月收治的30例患者为对象，详细分析了个性化视网膜光凝术的治疗有效性，报道如下。
1 资料与方法
1.1 一般资料
选取该院收治的30例糖尿病性视网膜病变患者，37只眼，其中男性19例23眼，女性11例14眼，年龄53～74岁，平均年龄(64.09±3.22)岁;体重45～75 kg，平均体重(57.09±5.33)kg;视力范围 0.06～0.9，平均视力(0.57±0.07);糖尿病病程 3 ～15 年，平均病程(9.76±1.57)年;其中非增生性糖尿病视网膜病变(NPDR)21例26眼，增生性糖尿病视网膜病变 (PDR)9例11眼。, 百拇医药(许科锋，殷俊涛)